These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Study of the effect of ethaverine and papaverine on post-ischemic arrhythmias in the awake dog]. Lacroix P; Linée P; Le Pollés JB C R Seances Soc Biol Fil; 1977; 171(5):1075-80. PubMed ID: 146549 [TBL] [Abstract][Full Text] [Related]
64. The cellular mechanisms of cardiac antiarrhythmic drug action. Binah O; Rosen MR Ann N Y Acad Sci; 1984; 432():31-44. PubMed ID: 6395766 [TBL] [Abstract][Full Text] [Related]
65. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers. Skibsbye L; Ravens U Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830 [TBL] [Abstract][Full Text] [Related]
66. Electrophysiological mechanisms for ventricular arrhythmias in patients with myocardial ischemia: anesthesiologic considerations, Part 1. Gallagher JD J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):495-505. PubMed ID: 9188004 [No Abstract] [Full Text] [Related]
68. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview. Dorian P; Newman D Europace; 2000 Oct; 2(4):277-85. PubMed ID: 11194593 [TBL] [Abstract][Full Text] [Related]
69. Assessment of antiarrhythmic drugs in experimental pharmacology. Caillard CG; Louis JC Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586 [No Abstract] [Full Text] [Related]
70. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats. von Philipsborn G Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683 [No Abstract] [Full Text] [Related]
71. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist]. Tamargo J; Valenzuela C; Delpón E Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683 [No Abstract] [Full Text] [Related]
72. The electrophysiology of Norpace (Part II). Befeler B Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398 [No Abstract] [Full Text] [Related]
73. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Olsson SB; Edvardsson N Am Heart J; 1981 Nov; 102(5):864-71. PubMed ID: 7304394 [No Abstract] [Full Text] [Related]
74. The monophasic action potential technique and its application in cardiac electropharmacology. Xie JT; January CT Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):557-67. PubMed ID: 8309319 [TBL] [Abstract][Full Text] [Related]
75. [Effect of anti-arrhythmia agents on the impulse conduction to the heart]. Kushakovskiĭ MS Kardiologiia; 1975 Sep; 15(9):137-45. PubMed ID: 7698 [No Abstract] [Full Text] [Related]
76. [The effect of dimethyltrilobine iodide on experimental arrhythmia and its electrophysiological action on myocardium]. Ming Z; Zhao GS Yao Xue Xue Bao; 1984 Jan; 19(1):12-5. PubMed ID: 6547803 [No Abstract] [Full Text] [Related]
77. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization]. Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862 [No Abstract] [Full Text] [Related]
78. Effects of lidocaine, propranolol, and sotalol on ouabain-induced changes in transmembrane potential of canine Purkinje fibers. Koerpel BJ; Davis LD Circ Res; 1972 Jun; 30(6):681-9. PubMed ID: 5025676 [No Abstract] [Full Text] [Related]
80. Antiarrhythmic drugs and ion channels: have we made the connection? Carmeliet E J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]